Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Dermatol ; 52(7): 813-9, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22835263

RESUMO

BACKGROUND: To date, no study has compared the clinical characteristics, malignancy associations, and treatment of dermatomyositis in predominantly Caucasian vs. Asian populations. MATERIALS AND METHODS: This prospective study was conducted to compare clinical characteristics of dermatomyositis, its relationship to malignancy, and treatment between two tertiary medical centers in the USA and Singapore. A total of 19 newly-diagnosed patients in the USA and 15 patients in Singapore were enrolled. Dermatomyositis or amyopathic dermatomyositis were diagnosed based on clinical assessment, skin and muscle biopsies, and muscle testing. RESULTS: Ninety-five percent of patients in the USA group were of Caucasian descent, while 93% of patients in the Singapore group were of Chinese descent. Both groups were predominantly female. Pruritus was the most common initial symptom reported in both groups, while periungual erythema and Gottron's papules were the most common skin presentations. Heliotrope eruption was more common in the Singapore group, occurring in 80% of patients vs. 32% of patients in the USA group (P = 0.007). Three patients in the Singapore group developed a malignancy, with two of these patients having nasopharyngeal carcinoma. None of the USA patients developed malignancies in a follow- up period of 2-5 years. Immunosuppressive steroid sparing therapy with hydroxychloroquine was more frequently used in Singapore, while topical tacrolimus was more frequently used in the USA. CONCLUSION: The clinical presentations of dermatomyositis vary among different ethnic populations. Chinese patients with dermatomyositis have a significant risk for nasopharyngeal carcinoma.


Assuntos
Carcinoma/complicações , Dermatomiosite/tratamento farmacológico , Dermatomiosite/patologia , Imunossupressores/uso terapêutico , Neoplasias Nasofaríngeas/complicações , Corticosteroides/uso terapêutico , Adulto , Idoso , Anticorpos Monoclonais Murinos/uso terapêutico , Povo Asiático , Conservadores da Densidade Óssea/uso terapêutico , Compostos de Cálcio/uso terapêutico , Dermatomiosite/complicações , Suplementos Nutricionais , Difosfonatos/uso terapêutico , Eritema/etiologia , Feminino , Humanos , Hidroxicloroquina/uso terapêutico , Masculino , Metotrexato/uso terapêutico , Pessoa de Meia-Idade , Ácido Micofenólico/análogos & derivados , Ácido Micofenólico/uso terapêutico , Óxidos/uso terapêutico , Estudos Prospectivos , Prurido/etiologia , Rituximab , Singapura , Tacrolimo/uso terapêutico , Centros de Atenção Terciária , Estados Unidos , Vitamina D/uso terapêutico , População Branca
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA